Protéus is a pioneer in protein engineering technologies, with now 20 years expertise in developing tailored enzymes and scaling-up biocatalytic processes. Proteus offers: - An exclusive and diversified microorganism collection (including micro-algae and thousands of bacteria and archaebacteria extremophiles strains) - 1,000 sequenced strains, combined with data mining tools, offering a unique pool of millions enzymes - Patented directed evolution technologies (EvoSightTM & L-ShufflingTM) to optimize enzymes performances - A multidisciplinary skilled team dedicated to custom bioprocess development for client’s applications - Seqens CDMO capabilities enabling large scale biocatalytic production of chemicals & pharmaceuticals - A range of proprietary Bioproducts
| Website | https://proteus.seqens.com/ |
| Revenue | $1.1 billion |
| Employees | 24 (6 on RocketReach) |
| Founded | 1997 |
| Phone | +33 1 69 09 77 85 |
| Industry | Biotechnology, Biotechnology Research, Science and Engineering, Drug Discovery |
| Web Rank | 12 Million |
| Keywords | Protein Engineering, Enzymes, Biocatalysis, Enzyme Development, Biotechnology, Microalgae, Industrial Enzymes, Biosynthesis, Biomanufacturing, Green Chemistry, Sustainable Chemistry, Bio-Based Solutions, Protein Production, Microbial Technology, Bioprocessing |
| Competitors | Shell, BASF, Dow, Solvay, SABIC, Evonik, Huntsman Corporation, COVESTRO ELASTOMERS SAS, FMC Corporation, LANXESS +40 more (view full list) |
Looking for a particular Proteus by Seqens employee's phone or email?
Proteus by Seqens Questions
The Proteus by Seqens annual revenue was $1.1 billion in 2026.
6 people are employed at Proteus by Seqens.
Top Proteus by Seqens Employees
